Age, Biography and Wiki
Chris Goodnow was born on 19 September, 1959 in Hong Kong, is an A Howard Hughes Medical Investigators. Discover Chris Goodnow's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 64 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
64 years old |
| Zodiac Sign |
Virgo |
| Born |
19 September 1959 |
| Birthday |
19 September |
| Birthplace |
Hong Kong |
| Nationality |
Hong Kong
|
We recommend you to check the complete list of Famous People born on 19 September.
He is a member of famous with the age 64 years old group.
Chris Goodnow Height, Weight & Measurements
At 64 years old, Chris Goodnow height not available right now. We will update Chris Goodnow's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Chris Goodnow Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Chris Goodnow worth at the age of 64 years old? Chris Goodnow’s income source is mostly from being a successful . He is from Hong Kong. We have estimated Chris Goodnow's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Chris Goodnow Social Network
Timeline
Christopher Carl Goodnow (born 19 September 1959) is an immunology researcher and the current executive director of the Garvan Institute of Medical Research.
He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney.
He holds dual Australian and US citizenship.
Born in Hong Kong in 1959 to Robert Goodnow and Jacqueline J. Goodnow AC, Goodnow grew up in Rome and Washington DC before moving to Sydney, Australia as a teenager.
He trained in veterinary medicine and surgery, immunochemistry and immunology at the University of Sydney and in DNA technology at Stanford University.
Goodnow is well known for leading a 1980 expedition to Indonesia's remote Mentawai Islands off the coast of Sumatra, discovering the now-famous surf breaks and a wave that is today considered one of the world's best, Macaronis.
After doctoral studies at Melbourne's Walter and Eliza Hall Institute of Medical Research and the University of Sydney, he joined the faculty of the Stanford University Medical School and the Howard Hughes Medical Institute in 1990.
There he established the concept of multiple immune tolerance checkpoints, a framework now widely used in cancer treatment with "checkpoint inhibitors", and revealed the function of key genes in these checkpoints.
In 1997 Goodnow joined the faculty at the Australian National University as professor and founding director of the Medical Genome Centre, leading its development into a major national research facility, the Australian Phenomics Facility.
In 2015 he joined the Garvan Institute of Medical Research as deputy director to translate genomic DNA sequence analysis of the human immune system into understanding the cause of immune disorders and developing more effective, personalised treatments.
During this period Goodnow oversaw the development of the Garvan-Weizmann Centre for Cellular Genomics in partnership with the Weizmann Institute of Science in Israel, the only multidisciplinary centre of its kind in the southern hemisphere as well as playing a key role in the development of the Clinical Immunogenomics Research Consortium Australia (CIRCA).
In May 2018, Goodnow was named Executive Director of the Garvan Institute.
